投稿须知/期刊简介:

About&nbsp;Journal of Clinical Oncology JCO&nbsp;is the primary forum of scientific discourse for the American Society of Clinical Oncology (ASCO). Published thrice monthly,&nbsp;JCO&nbsp;is the foremost peer-reviewed journal focusing on clinical cancer research and the authoritative source for current information on the diagnosis and treatment of patients with cancer.Why publish in&nbsp;Journal of Clinical Oncology?We offer rapid publication, high visibility, and the opportunity to have your research widely read.Speed of publicationAverage time from submission to first decision is just 10 days.Articles are published online first, weeks ahead of issue publication.A&nbsp;Rapid Communications&nbsp;program that fast-tracks important research.Impact and reachCited more than 133,000 times in 2014—ranked #1 among all clinical oncology journals.(1)2014 ISI Impact Factor: 18.443(1)Eigenfactor Rank: #1(1)Google Scholar h5-index Rank: #1(2)Over 6.6 million full-text article request each year.Read by more than 25,000 oncologists in over 120 countries.Accessed by nearly 10,000 academic, corporate, and government institutions worldwide.Benefits of partnering with ASCOGain instant recognition by publishing with ASCO, the most trusted source in oncology information.Have your article promoted via ASCO publications, websites, and social media.Take advantage of immediate&nbsp;open access&nbsp;options for your manuscript.The&nbsp;Journal of Clinical Oncology&nbsp;serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format,&nbsp;JCO&nbsp;strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of&nbsp;JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.<br> The acceptance rate for Original Reports is 13%.<br> JCO&nbsp;is published three times per month -- a total of 36 issues per year. <br> JCO&nbsp;provides free, or significantly discounted, online access to public health institutions in more than 100 developing countries through the&nbsp;World Health Organization''''s Health InterNetwork Access to Research Initiative&nbsp;(HINARI). Through HINARI,&nbsp;JCO&nbsp;aims to strengthen public health services by providing public health workers, researchers, and policy makers access to high-quality, relevant, and timely medical information.

期刊描述简介:

About Journal of Clinical Oncology JCO is the primary forum of scientific discourse for the American Society of Clinical Oncology (ASCO). Published thrice monthly, JCO is the foremost peer-reviewed journal focusing on clinical cancer research and the authoritative source for current information on the diagnosis and treatment of patients with cancer. Why publish in Journal of Clinical Oncology? We offer rapid publication, high visibility, and the opportunity to have your research widely read. Speed of publication Average time from submission to first decision is just 10 days. Articles are published online first, weeks ahead of issue publication. A Rapid Communications program that fast-tracks important research. Impact and reach Cited more than 133,000 times in 2014—ranked #1 among all clinical oncology journals.(1) 2014 ISI Impact Factor: 18.443(1) Eigenfactor Rank: #1(1) Google Scholar h5-index Rank: #1(2) Over 6.6 million full-text article request each year. Read by more than 25,000 oncologists in over 120 countries. Accessed by nearly 10,000 academic, corporate, and government institutions worldwide. Benefits of partnering with ASCO Gain instant recognition by publishing with ASCO, the most trusted source in oncology information. Have your article promoted via ASCO publications, websites, and social media. Take advantage of immediate open access options for your manuscript. The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer. The acceptance rate for Original Reports is 13%. JCO is published three times per month -- a total of 36 issues per year. JCO provides free, or significantly discounted, online access to public health institutions in more than 100 developing countries through the World Health Organization''''s Health InterNetwork Access to Research Initiative (HINARI). Through HINARI, JCO aims to strengthen public health services by providing public health workers, researchers, and policy makers access to high-quality, relevant, and timely medical information.